Clinical Trial Update: The Efficacy and Safety of Retreatment With TAI for Patients Who Showed TACE-resistant: a Randomized Controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

A randomized controlled trial evaluated retreatment with transarterial chemoembolization (TAI) in hepatocellular carcinoma patients who were resistant to TACE, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2, Phase 3 | Status: TERMINATED